Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Lars Verschuren
The BCR-ABL1 Inhibitors Imatinib and Ponatinib Decrease Plasma Cholesterol and Atherosclerosis, and Nilotinib and Ponatinib Activate Coagulation in a Translational Mouse Model
Frontiers in Cardiovascular Medicine
Cardiovascular Medicine
Cardiology
Icosabutate Exerts Beneficial Effects Upon Insulin Sensitivity, Hepatic Inflammation, Lipotoxicity, and Fibrosis in Mice
Hepatology Communications
Hepatology
Related publications
Modelling Ponatinib Resistance in Tyrosine Kinase Inhibitor-Naïve and Dasatinib Resistant BCR-ABL1+ Cell Lines
Oncotarget
Oncology
BCR-ABL1 and Beyond
Pathology
Forensic Medicine
Pathology
BCR-ABL1-independent PI3Kinase Activation Causing Imatinib-Resistance
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Reactive Oxygen Species and Mitochondrial DNA Damage and Repair in BCR-ABL1 Cells Resistant to Imatinib
BioResearch Open Access
Biochemistry
Genetics
Molecular Biology
Eruptive Melanocytic Nevi Associated With Ponatinib
JAAD Case Reports
Dermatology
Ponatinib Suppresses the Development of Myeloid and Lymphoid Malignancies Associated With FGFR1 Abnormalities
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Complete Molecular Response Induced by Nilotinib in a Patient Previously Treated With Imatinib, Nilotinib and Dasatinib
Clinical Management Issues
Medicine
Accounting
Management
Business
Nilotinib Treatment in Mouse Models of P190 BCR/Abl Lymphoblastic Leukemia
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
Rechallenge of Ponatinib in Chronic Myeloid Leukaemia After Hepatotoxicity
Hong Kong Medical Journal
Medicine
